Bnp Paribas Financial Markets

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
4,665
Total Value
30687523338
Accession Number
0001166588-25-000031
Form Type
13F-HR
CIK
0001166588
Manager Name
Bnp Paribas Financial Markets
Data Enrichment
85% identified
3,953 identified712 unidentified

Holdings

4,665 positions
Manager:
SEC
Search and click to pin securities to the top
Page 205 of 227
Inozyme Pharma, Inc.
INZY|45790W108
Shares:
3662(-45.2%)
Value:
$3.3M(-82.0%)
bluebird bio, Inc.
BLUE|09609G209
Shares:
679(-85.1%)
Value:
$3.3M(-91.3%)
126633205
126633205
Shares:
44
Value:
$3.3M
Black Diamond Therapeutics, Inc.
BDTX|09203E105
Shares:
2130(-48.2%)
Value:
$3.3M(-62.5%)
Werewolf Therapeutics, Inc.
HOWL|95075A107
Shares:
3365(-50.7%)
Value:
$3.3M(-67.6%)
Maiden Holdings, Ltd.
MHLD|G5753U112
Shares:
5586(-49.3%)
Value:
$3.2M(-82.9%)
RED ROBIN GOURMET BURGERS INC
RRGB|75689M101
Shares:
892(+541.7%)
Value:
$3.2M(+316.3%)
46435GAA0
46435GAA0
Shares:
129(+658.8%)
Value:
$3.1M(+663.6%)
Mural Oncology plc
MURA|G63365103
Shares:
2386(-1.7%)
Value:
$3.0M(-61.5%)
Golden Matrix Group, Inc.
GMGI|381098300
Shares:
1521(-61.9%)
Value:
$3.0M(-62.1%)
RENOVARO INC.
RENB|29350E104
Shares:
5516(-67.1%)
Value:
$3.0M(-78.6%)
Verde Clean Fuels, Inc.
VGAS|923372106
Shares:
891(-23.0%)
Value:
$3.0M(-36.5%)
Nautilus Biotechnology, Inc.
NAUT|63909J108
Shares:
3457(-52.3%)
Value:
$3.0M(-75.6%)
Corvus Pharmaceuticals, Inc.
CRVS|221015100
Shares:
933(+8.4%)
Value:
$3.0M(-35.6%)
Actinium Pharmaceuticals, Inc.
ATNM|00507W206
Shares:
1833(-68.1%)
Value:
$3.0M(-59.2%)
Sound Group Inc.
SOGP|53933L203
Shares:
1340(+42.5%)
Value:
$2.9M(+44.5%)
921946794
VYMI|921946794
Shares:
40
Value:
$2.9M
88145X108
88145X108
Shares:
347(+0.0%)
Value:
$2.9M(-13.9%)
Akoya Biosciences, Inc.
AKYA|00974H104
Shares:
2084(-51.1%)
Value:
$2.9M(-70.3%)
Ispire Technology Inc.
ISPR|46501C100
Shares:
1059(-44.8%)
Value:
$2.9M(-70.0%)